Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention
Woochan Kwon,Joo Myung Lee,Kyeong Ho Yun,Ki Hong Choi,Seung-Jae Lee,Jong-Young Lee,Sang Yeub Lee,Sang Min Kim,Jae Young Cho,Chan Joon Kim,Hyo-Suk Ahn,Chang-Wook Nam,Hyuck-Jun Yoon,Yong Hwan Park,Wang Soo Lee,Jin-Ok Jeong,Pil Sang Song,Joon-Hyung Doh,Sang-Ho Jo,Chang-Hwan Yoon,Min Gyu Kang,Jin-Sin Koh,Kwan Yong Lee,Young-Hyo Lim,Yun-Hyeong Cho,Jin-Man Cho,Woo Jin Jang,Kook-Jin Chun,David Hong,Taek Kyu Park,Jeong Hoon Yang,Seung-Hyuk Choi,Hyeon-Cheol Gwon,Joo-Yong Hahn,Young Bin Song,RENOVATE COMPLEX-PCI Investigators
DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.123.013359
Abstract:Background: The RENOVATE-COMPLEX-PCI (Randomized Controlled Trial of Intravascular Imaging Guidance Versus Angiography-Guidance on Clinical Outcomes After Complex Percutaneous Coronary Intervention) demonstrated that intravascular imaging-guided percutaneous coronary intervention (PCI) improved clinical outcome compared with angiography-guided PCI for patients with complex coronary artery lesions. This study aims to assess whether the prognostic benefit of intravascular imaging-guided procedural optimization persists in patients undergoing PCI for left main coronary artery disease. Methods: Of 1639 patients enrolled in the RENOVATE-COMPLEX-PCI, 192 patients with left main coronary artery disease were selected for the current prespecified substudy. Selected patients were randomly assigned to either the intravascular imaging-guided PCI group (n=138) or the angiography-guided PCI group (n=54). The primary end point was target vessel failure defined as a composite of cardiac death, target vessel-related myocardial infarction, or clinically driven target vessel revascularization. Results: At a median follow-up of 2.1 years (interquartile range 1.1 to 3.0 years), intravascular imaging-guided PCI was associated with lower incidence of primary end point compared with angiography-guided PCI (6.8% versus 25.1%; hazard ratio, 0.31 [95% CI, 0.13-0.76]; P=0.010). This significant reduction in primary end point was mainly driven by a lower risk of cardiac death or spontaneous target vessel-related myocardial infarction (1.6% versus 12.7%; hazard ratio, 0.16 [95% CI, 0.03-0.82]; P=0.028). Intravascular imaging-guided PCI was independently associated with a lower risk of primary end point, even after adjusting for various clinical factors (hazard ratio, 0.29 [95% CI, 0.12-0.72]; P=0.007). Conclusions: Intravascular imaging-guided PCI showed clinical benefit over angiography-guided PCI for left main coronary artery disease in reducing the risk of cardiac death, target vessel-related myocardial infarction, or target vessel revascularization. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03381872.